What is Micro-Leads?
Micro-Leads operates at the intersection of advanced engineering and clinical neuroscience, specializing in a proprietary closed-loop platform designed for high-resolution, minimally-invasive nerve stimulation. The company's core competency lies in the development of sophisticated therapeutic solutions, including spinal cord stimulation, peripheral nerve stimulation, and brain-computer interfaces. By integrating programmable electrodes with advanced neurostimulators, Micro-Leads provides a robust framework for personalized patient care. Their technological architecture, which utilizes real-time sensing to modulate therapeutic delivery, positions them as a critical innovator for medical device manufacturers and clinical research institutions focused on neuro-restorative outcomes.
How much funding has Micro-Leads raised?
Micro-Leads has raised a total of $10M across 1 funding round:
Other Financing Round
$10M
Other Financing Round (2019): $10M with participation from National Institutes of Health
Key Investors in Micro-Leads
National Institutes of Health
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing critical support for innovative medical breakthroughs.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Micro-Leads?
With this major enterprise-level funding, Micro-Leads is poised to transition from its current developmental phase toward broader clinical validation and commercial scalability. The strategic roadmap likely involves expanding the application of their closed-loop sensing technology to address a wider array of neurological conditions. As the company scales, the focus will shift toward optimizing manufacturing processes for their programmable electrode arrays and securing regulatory milestones necessary for widespread market adoption. This capital infusion serves as a catalyst for Micro-Leads to solidify its market position as a leader in the next generation of neuro-electronic therapeutics, potentially disrupting traditional treatment paradigms in the neuromodulation space.
See full Micro-Leads company page
